#

Moderna

: 21
Shares of pharmaceutical company Moderna plummeted after the results of a cancer vaccine trial were leaked / Photo: Tada Images / Shutterstock.com
News·
Moderna's stock plummeted 25% in a single day following a data leak regarding its cancer vaccine
Data on the subcutaneous form of Skyrizi likely drove the rise in AbbVies stock / Photo: ChrisStock82 / Shutterstock.com
News·
Pharmaceutical companies benefited from the sell-off in the AI sector. Which stocks are nearing their all-time highs?
“We hope this will be like COVID vaccines,” said Stacey Adam, a senior clinical officer at the Foundation for the NIH / Photo: Tada Images / Shutterstock
News·
Moderna hits four-year high as NYT reports U.S. cancer vaccine effort
Oil prices have resumed their rise amid concerns that the U.S. may resume strikes against Iran / Photo: Unsplash/Zbynek Burival
News·
Morning in New York: Oil Risk Returns
Novavax was off 13% on Tuesday as of this writing / Photo: Cristian Storto / Shutterstock.com
News·
Vaccine stocks retreat after WHO calls plague risk 'low'
Warner Bros. shares will soon be removed from the Nasdaq 100 and the S&P 500—which stocks will take their place / Photo: Schager / Shutterstock
News·
Warner Bros. shares will be removed from the Nasdaq 100 and the S&P 500. Who will take their place?
Citis new price target for Moderna shares suggests a 60% drop in the pharmaceutical companys stock price / Photo: Dmitriy Melnikov / Shutterstock
News·
Moderna's Stock Rally Was "Excessive": Why a Citi Analyst Expects It to Fall 60%
A Rothschild analyst deemed the markets reaction to the results of Modernas skin cancer vaccine trials to be excessive / Photo: Shutterstock.com / Panaceum Media
News·
An analyst called Moderna's stock overvalued after it rose 400% since the start of the year
BioNTech and Roche have halted trials of an experimental personalized mRNA immunotherapy for patients with stage II–III colorectal cancer / Photo: Kittyfly / Shutterstock.com
News·
BioNTech and Roche have halted a cancer vaccine trial. What does this mean for the industry?
Moderna will use the proceeds to fund the development of a cancer drug and to pay off debt / Photo: Shutterstock.com / Dmitriy Melnikov
News·
Moderna to Raise $2 Billion Following a Surge in Its Stock Price — Including Funding for a Cancer Vaccine
It will not be possible to automatically extend the use of a personalized vaccine against melanoma recurrence to other types of cancer / Photo: Poetra.RH / Shutterstock.com
News·
Not a Panacea: What Might Investors Have Overlooked in the News About the “Cancer Vaccine”?
Modernas 177% stock surge led to multibillion-dollar paper losses for short sellers / Photo: Shutterstock.com / Tada Images
News·
Moderna's stock price nearly tripled, resulting in $5.5 billion in paper losses for short sellers
Load more